PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 7, 2024Expert Review of Pharmacoeconomics & Outcomes Research4 citationsOpen Access

Cost-effectiveness analysis comparing single-pill combination of perindopril/amlodipine/indapamide to the free equivalent combination in patients with hypertension from an Italian national health system perspective

View Full Paper
PLPierre LévyTLTobiasz LemańskiCCCatriona Crossan

Key Points

Key points are not available for this paper at this time.

Abstract

Objective To evaluate the cost-effectiveness of a single-pill combination (SPC) of perindopril/amlodipine/indapamide versus its free equivalent combination (FEC) in adults with hypertension in Italy.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Lévy et al. (2024) studied this question.

synapsesocial.com/papers/68e65aacb6db6435875e8f63https://doi.org/10.1080/14737167.2024.2365988
Ask AI
Helpful
Bookmark
Share
View Full Paper